Second Genesis Inc is categorized under Outpatient Drug Clinics in Silver Spring, MD and active since 1971.
Second Genesis Inc was established in 1971, and today employs 1 to 4, earning Unknown per year. This is a Outpatient Drug Clinics business, which does work in the B2C market, and is classified as a Outpatient Drug Clinics, under code number 8133190 by the NAICS.
If you are seeking more information, feel free to contact Thomas Barrett, President at the company’s single location by writing to 8611 2nd Avenue # 300, Silver Spring, Maryland MD 20910 or by phoning (301) 563-1545. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Second Genesis Inc |
| Contact Person: | Thomas Barrett, President |
| Address: | 8611 2nd Avenue # 300, Silver Spring, Maryland 20910 |
| Phone Number: | (301) 563-1545 |
| Website Address: | secondgenesis.org |
| Annual Revenue (USD): | Unknown |
| Founded: | 1971 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Drug Clinics |
| SIC Code: | 8093 |
| NAICS Code: | 8133190 |
| Share This Business: |
Second Genesis Inc was started in 1971 to provide professional Outpatient Drug Clinics under the SIC code 8093 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Thomas Barrett, President for inquiries that concern Second Genesis Inc by calling the company number (301) 563-1545, as your correspondence is most welcome. Additionally, the physical location of the single location of Second Genesis Inc can be found at the coordinates 38.99735,-77.03387 as well as the street address 8611 2nd Avenue # 300 in Silver Spring, Maryland 20910.
For its online presence, you may visit Second Genesis Inc’s website at secondgenesis.org and engage with its social media outlets through on Twitter and on Facebook.